Was Tim telling us today, that 113 is working on EGFR?
As part of his response to a question about 113, Tim said:
"And then ESMO is really likely also to reflect largely our Phase 1 experience. There could be some phase 11 information in there AND WHAT WE'D GENERALLY GUIDED TO IS THAT IT'S MORE LIKELY THAT THERE'LL BE MORE OF AN INTERESTING UPDATE ON THE EGFR SIDE OF THINGS GIVEN THAT WE'RE TRYING TO REFINE THE PATIENT POPULATION THAT COME IN, IN THAT SIDE OF THE FILE AT ESMO RATHER THAN ASCO"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.